Implications of CTCs in Early Breast Cancer Implications of CTCs in Early Breast Cancer
Can CTCs be used to predict prognosis and response to neoadjuvant chemotherapy in nonmetastatic breast cancer?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 20, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

How Complementary Cancer Therapies Can Increase Risk of Early Death
People diagnosed with cancer have a multitude of treatment options, many of which are standard therapies that have been well-studied to improve their chances of surviving their disease or avoiding recurrence. But people are increasingly also folding in complementary medicine approaches — which include nutrients, herbal remedies and other so-called natural supplements — with their cancer treatment regimes. While these are not nearly as well-studied as conventional therapies like surgery, radiation and chemotherapy, many people rely on them because they believe they can improve their chances of surviving their ca...
Source: TIME: Health - July 19, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news

Roche still awaiting Tecentriq survival data in key study
Roche's Tecentric immunotherapy mixed with chemotherapy has not yet achieved a hoped-for overall survival target in first-line lung cancer treatment, the Swiss drugmaker said on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - July 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Roche ’s Tecentriq in combination with pemetrexed and platinum-based chemotherapy reduced the risk of disease worsening or death in the initial treatment of people with advanced lung cancer
Roche today announced that the Phase III IMpower132 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the combination of Tecentriq ® (atezolizumab) plus chemotherapy (cisplatin or carboplatin plus pemetrexed) reduced the risk of disease worsening or death (PFS) compared to chemotherapy alone in the initial (first-line) treatment of advanced non-squamous non-small cell lung cancer (NSCLC). (Source: Roche Investor Update)
Source: Roche Investor Update - July 19, 2018 Category: Pharmaceuticals Source Type: news

Roche ’s Tecentriq in combination with pemetrexed and platinum-based chemotherapy reduced the risk of disease worsening or death in the initial treatment of people with advanced lung cancer
Roche today announced that the Phase III IMpower132 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the combination of Tecentriq ® (atezolizumab) plus chemotherapy (cisplatin or carboplatin plus pemetrexed) reduced the risk of disease worsening or death (PFS) compared to chemotherapy alone in the initial (first-line) treatment of advanced non-squamous non-small cell lung cancer (NSCLC). (Source: Roche Media News)
Source: Roche Media News - July 19, 2018 Category: Pharmaceuticals Source Type: news

Overcoming resistance to a standard chemotherapy drug
(Emory Health Sciences) Winship researchers identified an enzyme responsible for making tumors and cancer cell lines resistant to cisplatin, along with an experimental drug, lestaurtinib, which targets that enzyme. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 19, 2018 Category: Cancer & Oncology Source Type: news

Trial Adds Gemcitabine to Pleural Mesothelioma HIOC Therapy
Results of a phase I clinical trial highlight how the addition of a drug to an existing treatment option appears safe and may improve outcomes in certain patients with malignant pleural mesothelioma (MPM). The primary goal of the trial was to determine the maximum tolerated dose of gemcitabine added to cisplatin when these drugs are delivered together as heated intraoperative chemotherapy (HIOC) during surgery. Researchers have studied cisplatin alone for HIOC. The addition of gemcitabine — a chemotherapy drug often used to treat pancreatic, ovarian and breast cancers — is new. The Journal of Thoracic Oncology...
Source: Asbestos and Mesothelioma News - July 18, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Health Basics QUIZ: Which kills more Americans, cancer or chemotherapy?
(Natural News) One in every three Americans will “contract” some form of cancer in their lifetime, and only about 50 percent will survive that attack. Those are some grim statistics, huh? Now get this: Has any doctor reviewed with you or your loved ones the odds of chemotherapy actually working, or what the statistics are... (Source: NaturalNews.com)
Source: NaturalNews.com - July 18, 2018 Category: Consumer Health News Source Type: news

Rejuvenix Ready to Reduce Cancer Side Effects
Rejuvenix Technologies LLC of Perryville has patented a technology that aims to reduce side effects for cancer patients undergoing chemotherapy treatment by delivering drugs directly to tumors. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - July 16, 2018 Category: American Health Source Type: news

New research finds that routine breast cancer tests lead to unnecessary mastectomies and chemotherapy
(Natural News) Are women’s fears of breast cancer driving them to get unnecessary, dangerous treatments like chemotherapy and mastectomies? A pair of studies shows just how much women are endangering their lives for no benefit after getting a diagnosis. The first is an unsettling U.K. study that looked at more than 2,700 women who were... (Source: NaturalNews.com)
Source: NaturalNews.com - July 15, 2018 Category: Consumer Health News Source Type: news

RenovoRx sets its sights on localized treatment of pancreatic cancer
People living with pancreatic cancer find themselves facing devastating odds – the five-year survival rate is in the single digits, according to the American Cancer Rate. Pursuing treatment often means dealing with the side effects of systemic chemotherapy, including hair loss, fatigue and neuropathy. Shaun Bagai and his team at RenovoRx think that their catheter could help usher in a targeted treatment option for these patients. The company’s RenovoCath dual-balloon infusion catheter is designed to localize the delivery of chemotherapy to a pancreatic tumor, eliminating the need for systemic chemothe...
Source: Mass Device - July 13, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Catheters Clinical Trials Drug-Device Combinations Food & Drug Administration (FDA) Oncology Pharmaceuticals RenovoRx Source Type: news

Natural solution for damage done by chemo: Omega 3s found to treat wounds from inflamed mucous membranes in cancer patients
(Natural News) Omega-3 fatty acids can be used to treat and prevent oral mucositis in patients undergoing mucotoxic cancer chemotherapy. The double-blind, randomized study, published in the journal Wounds, detailed the effectiveness and route of administration of omega-3 fatty acids in patients receiving chemotherapy in Iranian hospitals. Mucositis is characterized by soreness or swelling in the mouth which... (Source: NaturalNews.com)
Source: NaturalNews.com - July 13, 2018 Category: Consumer Health News Source Type: news

There ’s More Good News About Immune Therapies for Cancer
There has been welcome excitement in the cancer field lately about immune-based treatments, which co-opt the body’s own immune system to fight tumors. The so-called immunotherapies have transformed everything from solid cancers like melanoma and lung, to blood cancers like lymphoma and leukemia. In the latest study involving one of the first immunotherapies approved by the Food and Drug Administration, researchers report that an immune-based approach can even help people with advanced melanoma, which has spread to the brain, to live longer. The study, published in Cancer Immunology Research, included more than 2,700 ...
Source: TIME: Health - July 12, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Innovation Health Source Type: news

Roche announces submission of supplemental New Drug Application for Venclexta for people with previously untreated acute myeloid leukaemia who are ineligible for intensive chemotherapy
Roche today announced submission of a supplemental New Drug Application (sNDA) to the United States (U.S.) Food and Drug Administration (FDA) for Venclexta  (venetoclax), in combination with a hypomethylating agent or in combination with low dose cytarabine (LDAC), for treatment of people with previously untreated acute myeloid leukaemia (AML) who are ineligible for intensive chemotherapy. (Source: Roche Investor Update)
Source: Roche Investor Update - July 12, 2018 Category: Pharmaceuticals Source Type: news

Glenmark launches Akynzeo in India under licensing pact with Helsinn
Glenmark Pharmaceuticals today launched Akynzeo, a drug used for prevention chemotherapy-induced nausea and vomiting, in India and Nepal. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 12, 2018 Category: Pharmaceuticals Source Type: news

Common Chemotherapy Drug Is More Effective When Given With Dietary Supplement In Mice
New research suggests one of the oldest cancer chemotherapy agents in the world could be improved by supplementing with a common dietary amino acid. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 11, 2018 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

Surgery Plus HIPEC Only ‘ Potential for Cure ’ of Peritoneal Mesothelioma
This study contributes to a better understanding of how CRS and HIPEC work and who is likely to receive the best benefit from this combination treatment. For patients with the most aggressive peritoneal mesothelioma cancers, additional options — such as immunotherapy or ongoing, post-surgical delivery of chemotherapy into the peritoneal cavity — may be additional treatments to consider. The post Surgery Plus HIPEC Only ‘Potential for Cure’ of Peritoneal Mesothelioma appeared first on Mesothelioma Center - Vital Services for Cancer Patients & Families. (Source: Asbestos and Mesothelioma News)
Source: Asbestos and Mesothelioma News - July 10, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Toddler is diagnosed with ovarian cancer at just 15 months old
Harlow, from California, has undergone grueling chemotherapy, surgery and a stem cell transplant. She was diagnosed with the disease, which usually affects women over 50, in April 2016. (Source: the Mail online | Health)
Source: the Mail online | Health - July 9, 2018 Category: Consumer Health News Source Type: news

Brave toddler has a 50-50 chance of survival after being diagnosed with aggressive ovarian cancer
Harlow, from California, has undergone grueling chemotherapy, surgery and a stem cell transplant. She was diagnosed with the disease, which usually affects women over 50, in April 2016. (Source: the Mail online | Health)
Source: the Mail online | Health - July 9, 2018 Category: Consumer Health News Source Type: news

Younger patients don't attain survival benefit from current rectal cancer treatment recommendations
(Wiley) A new study reveals that individuals younger than 50 years of age who are diagnosed with rectal cancer do not experience an overall survival benefit from currently recommended treatments. Specifically, the addition of chemotherapy and radiation to surgery does not prolong life for these patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 9, 2018 Category: International Medicine & Public Health Source Type: news

Adjuvant Chemotherapy for ER+ Breast Cancer Adjuvant Chemotherapy for ER+ Breast Cancer
Genomic assays and targeted therapies are helping to reduce the use of chemotherapy.Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 6, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Geriatric Assessments Could Fine-Tune Cancer Care for Older Adults Geriatric Assessments Could Fine-Tune Cancer Care for Older Adults
The American Society of Clinical Oncology issued a new guideline that recommends adults 65 and older receive a geriatric assessment when considering or undergoing chemotherapy.Kaiser Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 5, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Medical News Today: Chemotherapy enhanced by disused antipsychotic
Tumors often become resistant to chemotherapy. A new study describes how a defunct psychoactive drug might help to reverse this process. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 5, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Research Reveals Immunotherapy More Effective in Men
For mesothelioma patients, immunotherapy is mostly available through clinical trials at this time. Immunotherapy is a relatively new way to treat cancer, and doctors still are learning who will respond best to these novel therapies. Newly released medical research has found men seem to respond better to immunotherapy than women. But this doesn’t mean immunotherapy is off the table for women with mesothelioma. You should learn all you can about how immunotherapy works, why it may or may not be right for you and how you can best prepare yourself if you decide an immunotherapy clinical trial is right for you. Thorough ...
Source: Asbestos and Mesothelioma News - July 3, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

FLT3 Inhibitor Quizartinib Improves Survival in AML FLT3 Inhibitor Quizartinib Improves Survival in AML
For the first time, a single agent has produced a survival benefit when compared to standard chemotherapy in a subgroup of patients with relapsed or refractory acute myeloid leukemia.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 2, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Artificial ovary may help women conceive after chemotherapy
Researchers have developed an " artificial ovary " from human tissue and eggs that could help women have children after medical treatments that damage fertility. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 2, 2018 Category: Consumer Health News Source Type: news

Roche reports good news in breast cancer combo trial
Roche announced that a Phase III trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 2, 2018 Category: Pharmaceuticals Source Type: news

New cell-based immunotherapy treatments give hope to cancer patients
The immune system is incredibly efficient and well designed to recognize foreign invaders and kill them. This is how it protects us against infection. However, as cancer cells have evolved, with the ability to hide and trick the immune system in order to survive, the immune system has trouble eliminating them. As doctors and researchers, we have to be smarter. When we think of conventional chemotherapy drugs, we think of drugs that are essenti ally cellular poisons – they kill cancer cells by… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 2, 2018 Category: Biotechnology Authors: Dr. Scott Solomon Source Type: news

Artificial ovary could help women conceive after chemotherapy and cancer treatment
SCIENTISTS have made "exciting" progress in the development of artificial "ovaries" to help preserve women's fertility. (Source: Daily Express - Health)
Source: Daily Express - Health - July 2, 2018 Category: Consumer Health News Source Type: news

Roche 'highly encouraged' by Tecentriq results in breast cancer
ZURICH (Reuters) - Swiss drugmaker Roche said on Monday that a trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer. (Source: Reuters: Health)
Source: Reuters: Health - July 2, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Artificial ovary fertility treatment developed by scientists
The treatment is aimed at women who are at risk of becoming infertile, such as those who receive chemotherapy. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - July 1, 2018 Category: Consumer Health News Source Type: news

'Artificial ovary' could help women conceive after chemotherapy
Development could allow women to have children after fertility-damaging treatmentsDoctors have made an “artificial ovary” from human tissue and eggs in a bid to help women have children after cancer treatment and other therapies that can damage female fertility.The team in Copenhagen showed that a lab-made ovary could keep human eggs alive for weeks at a time, raising hopes that the approach could one day help women have families after harsh treatments such as chemo- and radiotherapy.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 1, 2018 Category: Science Authors: Ian Sample Science editor Tags: Medical research Fertility problems Science Health Society IVF Cancer Menopause Denmark Women Europe World news Life and style Source Type: news

It ’s easy to host a blood drive at your business
Every two seconds — that’s how often someone in the U.S. needs blood. And, according to the American Red Cross – Ohio Buckeye Region, approximately 500 donations are needed each day in Central Ohio. Blood is needed for routine surgeries, chemotherapy, the treatment of chronic illnesses like sickle cell disease and in saving lives after a traumatic event— one car accident victim can require as many as 100 pints of blood. But despite advancements made in modern medicine, we can’t manufacture… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 1, 2018 Category: Biotechnology Authors: Nationwide Source Type: news

It ’s easy to host a blood drive at your business
Every two seconds — that’s how often someone in the U.S. needs blood. And, according to the American Red Cross – Ohio Buckeye Region, approximately 500 donations are needed each day in Central Ohio. Blood is needed for routine surgeries, chemotherapy, the treatment of chronic illnesses like sickle cell disease and in saving lives after a traumatic event— one car accident victim can require as many as 100 pints of blood. But despite advancements made in modern medicine, we can’t manufacture… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 1, 2018 Category: Pharmaceuticals Authors: Nationwide Source Type: news

Chemotherapy May Alter Brain Activity in Survivors of Childhood ALL Chemotherapy May Alter Brain Activity in Survivors of Childhood ALL
Chemotherapy for childhood acute lymphoblastic leukemia (ALL) is associated with alterations in brain activation during attention and executive-function tasks, researchers report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 29, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

It's true: Government kidnaps children and separates them from their mothers... learn the truth about "medical kidnapping" and forced vaccinations, chemotherapy
(Natural News) Democrats, the mainstream media, and other Trump haters are right now going berserk over reports about illegal alien children allegedly being separated from their illegal alien parents at the Mexican border, claiming that it represents a horrible and unprecedented injustice that blatantly violates basic human rights. But these same virtue-signalers are nowhere to... (Source: NaturalNews.com)
Source: NaturalNews.com - June 29, 2018 Category: Consumer Health News Source Type: news

Anti-mucositis gel developed at UGR to be widely available by 2022
(University of Granada) Researchers from the University of Granada have developed new medication which could help to treat and prevent chemotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients. The melatonin compound, in the form of a gel, has now passed phases 1 and 2 of clinical trials and is expected to be on sale by 2022. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 29, 2018 Category: International Medicine & Public Health Source Type: news

CIRM awards City of Hope $3.7 million to develop a glioblastoma clinical trial
(City of Hope) The California Institute for Regenerative Medicine (CIRM) board today awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients that will genetically engineer their stem cells to better tolerate chemotherapy's side effects, allowing them to receive higher doses of the therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2018 Category: Cancer & Oncology Source Type: news

MM Patients May Benefit From Surgery, Regardless of Lesion Location
Preoperative pain, prothrombin time activity (PTA), albumin, urine protein, and postoperative chemotherapy appeared to be associated with prognosis. (Source: CancerNetwork)
Source: CancerNetwork - June 27, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news

NIH Opening First Mesothelioma Clinical Trial for Lynparza
The National Institutes of Health (NIH) in Bethesda, Maryland, is opening the first mesothelioma clinical trial involving the immunotherapy drug Lynparza (olaparib), a protein inhibitor and targeted therapy already used effectively with breast and ovarian cancers. The phase II clinical trial, for patients previously treated with standard chemotherapy, is designed to gauge the response rate in pleural and peritoneal mesothelioma. Mesothelioma specialist Dr. Raffit Hassan of the National Cancer Institute (NCI) is the senior investigator for the single-center trial, which hopes to enroll at least 40 patients. Earlier research...
Source: Asbestos and Mesothelioma News - June 27, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Sodium Thiosulfate Post-Cisplatin May Lessen Hearing Loss
WEDNESDAY, June 27, 2018 -- Delayed administration of sodium thiosulfate after cisplatin chemotherapy may prevent treatment-related hearing loss in children with standard-risk hepatoblastoma without affecting survival outcomes, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 27, 2018 Category: Pharmaceuticals Source Type: news

Polio Virus Could Help Treat Brain Cancer. Here ’s How
The idea that viruses may be co-opted to do good rather than harm isn’t entirely new; researchers have been attempting to harness the power of viruses and bacteria for more than a century. Vaccines are the shining example of using bad bugs to do good in priming the immune system to fight disease. But disease-causing viruses aren’t always easy to corral, and attempts to use them to activate the immune system against things other than fellow bacteria and viruses — including cancer, for example — have not been so successful. There is only one approved virus-based treatment for cancer, which uses herpes...
Source: TIME: Health - June 26, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news

Lenalidomide/Rituximab Combo Effective in Advanced FL
Efficacy of lenalidomide plus rituximab was similar to chemotherapy induction in previously untreated symptomatic FL, with a better safety profile. (Source: CancerNetwork)
Source: CancerNetwork - June 26, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news

Roche's Tecentriq cocktail boosts survival in small cell lung cancer
ZURICH (Reuters) - Swiss drugmaker Roche said on Monday that a cocktail of its immunotherapy Tecentriq with chemotherapy boosted survival of patients with previously untreated extensive-stage small cell lung cancer compared with chemotherapy alone. (Source: Reuters: Health)
Source: Reuters: Health - June 25, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Roche ’s TECENTRIQ in combination with chemotherapy helped people with previously-untreated extensive-stage small cell lung cancer live significantly longer compared to chemotherapy
Roche today announced that the Phase III IMpower133 study met its co-primary endpoints of overall survival (OS) and progression-free survival (PFS) at its first interim analysis. (Source: Roche Investor Update)
Source: Roche Investor Update - June 25, 2018 Category: Pharmaceuticals Source Type: news

Roche ’s TECENTRIQ in combination with chemotherapy helped people with previously-untreated extensive-stage small cell lung cancer live significantly longer compared to chemotherapy
Roche today announced that the Phase III IMpower133 study met its co-primary endpoints of overall survival (OS) and progression-free survival (PFS) at its first interim analysis. (Source: Roche Media News)
Source: Roche Media News - June 25, 2018 Category: Pharmaceuticals Source Type: news

T-cell leukaemia: Cancer cells take advantage of 'survival protein'
(KU Leuven) Cancer researchers at KU Leuven have shown that some patients with T-cell leukaemia produce too much of the BCL-2 protein. Cancer cells take advantage of this 'survival protein' which allows them to escape chemotherapy. A drug suppressing this BCL-2 shows promising results. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 25, 2018 Category: International Medicine & Public Health Source Type: news

Slow Medicine: Less Chemotherapy for Breast Cancer
(MedPage Today) -- Using precision medicine to reduce treatment harm should be'top priority'(Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 22, 2018 Category: American Health Source Type: news

SA researchers exploring use of re-purposed cancer drugs to combat deadly TB
Scientists at San Antonio ’s Texas Biomedical Research Institute are studying the effectiveness of promising experimental cancer chemotherapy drugs in defeating another life-threatening disease — tuberculosis, or TB.  That exploration could help beat back an illness that has surpassed AIDS as the world’s single most lethal infectious disease. A scientific team led by Texas Biomed’s Eusondia Arnett have pinpointed a mechanism in regulating cell death called apoptosis that is a potential… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 22, 2018 Category: Health Management Authors: W. Scott Bailey Source Type: news

Academy of Laser Dentistry Announces Call for Abstracts for ALD 2019 Annual Session
“The Laser-Systemic Connection: Lighting the Way to a Healthier Mouth and Body” will Take Place in Dallas on April 4-6, with Opening Keynoteby Leading Oral-Systemic Health Advocate, Charles Whitney, MDCoral Springs, FL – June 18, 2018 –The Academy of Laser Dentistry (ALD), the only independent and unbiased non-profit association dedicated to improving patient care with the proper use of laser technology, recently issued a call for abstracts for its upcoming annual meeting.Known internationally as “dentistry’s laser meeting”, ALD 2019 is at the Hilton Anatole in Dallas from April 4t...
Source: Dental Technology Blog - June 22, 2018 Category: Dentistry Source Type: news